论文部分内容阅读
发表于JACC的一项荟萃分析反映,舒张性心力衰竭(DHF)经药物治疗,改善运动耐量但不降低死亡率。此结果与业已肯定的收缩性心力衰竭(HF)的药物治疗效果不同,它的作者提示,可能反映DHF有更大的兼患疾病负荷。
A meta-analysis published in the JACC reflects pharmacological treatment of diastolic heart failure (DHF) to improve exercise tolerance without reducing mortality. This result is different from that of established medical therapy for systolic heart failure (HF), and its authors suggest that it may reflect a greater risk burden for DHF.